Skip to main content
. 2016 Sep 1;11(9):e0161753. doi: 10.1371/journal.pone.0161753

Fig 1. CONSORT flow diagram: number of individuals assessed for eligibility, enrolled and randomized to vaccine or placebo, followed-up and analysed.

Fig 1

T1: MVA prime, sequential gp140 boost (M/M/P/P); T2 (MP/MP): concurrent MVA/gp140; T3 (D/D/M/M): DNA prime, sequential MVA boost; T4 (D/D/MP/MP): DNA prime, concurrent MVA/gp140 boost) or placebo. P1-P4 = placebo.